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Abstract
Background: Inhalant use is among the most pernicious and poorly understood forms of
adolescent substance use. Many youth in the juvenile justice system have used inhalants, but little
is known about inhalant use disorders (IUDs) in antisocial youth populations. The purpose of this
study was to examine the prevalence, clinical features, and latent structure of DSM-IV IUDs in a
state population of antisocial youth.
Methods: Cross-sectional survey conducted in 2003. Of 740 youth residing in Missouri State
Division of Youth Services' (MDYS) residential treatment facilities at the time the study was
conducted, 723 (97.7%) completed interviews. Eighty-seven percent were male, with a mean age
of 15.5 (SD = 1.2). Nearly 4 in 10 youth (38.5%; n = 279) reported lifetime inhalant use. Youth
ranged from very mildly to severely antisocial.
Results: Of 279 inhalant users, 52 (18.6%) met DSM-IV inhalant abuse criteria and 79 (28.3%) met
inhalant dependence criteria. Five of 10 IUD criteria were met by > 10% of the total sample. Latent
class analyses demonstrated a substantial concordance between DSM-IV-defined IUDs and an
empirically-derived classification based on responses to DSM-IV IUD diagnostic criteria.
Conclusion: IUDs and constituent criteria were prevalent among youth in the juvenile justice
system. Two groups of problem inhalant users were identified, symptomatic users-DSM-IV inhalant
abuse and highly symptomatic users-DSM-IV inhalant dependence, which differed primarily in
severity of inhalant-related problems. Inhalant screening, prevention and treatment efforts in
juvenile justice settings are rarely delivered, but critically needed.
Background
Inhalant use and formal DSM-IV inhalant use disorders
(IUDs) remain a curious case study in the annals of psy-
chiatric epidemiology. For more than thirty years, nation-
ally representative surveys have identified inhalant use as
among the most prevalent forms of adolescent substance
use [1,2]. For example, findings from the 2006 Monitor-
ing the Future survey indicated that 16.1% of U.S. 8th grad-
ers had used inhalants, compared to 15.7% who had used
marijuana/hashish, and 7.3%, 3.4%, 3.4%, and 1.4%
who had used amphetamines, hallucinogens, cocaine,
and heroin, respectively [3]. Wu and colleagues recently
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had used inhalants based on data from the National Sur-
vey on Drug Use and Health [4].
A small corpus of animal studies, case reports, and clinical
investigations further suggests that malignant health and
social outcomes may attend adolescent inhalant use.
Inhalant use has been implicated in documented cases of
cardiac, renal, and liver toxicity and hepatorenal failure
[5-7], bowel and bladder dysfunction [8], bone marrow
suppression and reduced T-cell responsivity [9,10], irre-
versible congestive heart failure [11], severe neurological
damage and cognitive dysfunction [12,13], effects in off-
spring similar to those of fetal alcohol syndrome [14], and
a host of psychiatric, social, academic, and interpersonal
functional impairments [15-19].
Despite these troubling findings, inhalant use remains
poorly understood and the least studied of the psychoac-
tive substances of abuse. In his presidential address to the
College on Problems of Drug Dependence, Balster
referred to inhalant use as "the hidden epidemic," noting
the curious disjunction between the seriousness of the
problem and the insubstantial scientific and clinical
responses to it [20]. IUDs have been included in the Diag-
nostic and Statistical Manual of Mental Disorders (DSM)
since 1980, although the brief discussion of these disor-
ders in DSM-IV is testament more to the sheer absence of
available findings vis-à-vis prevalence, course, subtypes,
comorbid mental health and medical conditions, and spe-
cific clinical and sociodemographic features than a useful
guide to the diagnosis of these disorders [21]. Additional
research on IUDs is needed to support a more refined,
substantive, and clinically useful discussion of IUDs in
DSM-V.
One particularly important unresolved issue concerns the
validity of the DSM-IV distinction between inhalant abuse
and inhalant dependence disorders. Although the generic
DSM-IV substance dependence disorder criteria set
applied to most substance use disorders includes a crite-
rion reflecting presence versus absence of a characteristic
withdrawal syndrome, this criterion is not included in the
inhalant dependence disorder criteria set. Further, as rec-
ognized in DSM-IV [21], other generic substance use dis-
order criteria may have been included in the IUD criteria
sets inappropriately. For example, one generic substance
dependence criterion assesses whether "a great deal of
time is spent in activities necessary to obtain the sub-
stance, use the substance, or recover from its effects."
However, it is unlikely that inhalant users spend a great
deal of time accessing inhalants, given their ubiquity in
the physical environment. We are not aware of any prior
studies of the latent structure of DSM-IV IUDs. Findings of
this nature could shed light on current proposals to move
from a categorical (abuse vs. dependence) to unidimen-
sional conceptualization of substance use disorder (i.e.,
dependence) in DSM-V [22-25]. Further research on IUDs
in general is needed to improve screening, treatment and
prevention.
The current study attempts to address these gaps in knowl-
edge by focusing on a large sample of delinquent youth.
Delinquent youth have among the highest rates of inha-
lant use identified in prior studies of community, clinical,
and criminological samples. These findings suggest that
delinquent youth may also be at comparatively high risk
for IUDs. For example, Howard and Jenson identified life-
time inhalant use in 34.3% of 475 adolescents on proba-
tion in Utah [26]. Similar results were reported by
Howard, Balster, Cottler, Wu, and Vaughn [27], who
found that nearly 40 percent of 723 antisocial youth resid-
ing in Missouri State Division of Youth Services' residen-
tial rehabilitation facilities had used inhalants for the
expressed purpose of becoming intoxicated. Howard et al.
[27] examined characteristics of inhalant use in a state
population of delinquent youth, including prevalence
and patterns of use and differences between inhalant users
and nonusers. Findings indicated that race/ethnicity, geo-
graphic area of residence, fearlessness, sucidality, and
polydrug use distinguished inhalant users and nonusers
in multiple logistic regression analyses.
Using the same data source as Howard et al. [27], Perron
and Howard [28] examined correlates of IUDs. They
found that delinquents with IUDs (particularly depend-
ence) reported more extensive histories of antisocial
behavior, trauma, substance-related problems, suicidal
ideation, and higher current levels of anxious/depressive
symptoms than did inhalant nonusers or users without
IUDs. Youth with IUDs had significantly more substance-
related problems and greater suicidal ideation than inha-
lant nonusers.
The current study extends Howard et al.'s [27] and Perron
and Howard's [28] investigations by examining the prev-
alence and diagnostic performance of DSM-IV inhalant
abuse and dependence disorders and their constituent cri-
teria. These issues were not examined in the prior reports
[27,28] but are important. More specifically, studies of
community and clinical samples reveal that high rates of
lifetime inhalant use do not necessarily imply high rates
of DSM-IV IUDs [29,30]. However, statewide surveys
[26,27] indicate that delinquent youth, particularly those
in the juvenile justice system, may be at high risk for IUDs.
Our review of the scientific literature pertaining to inha-
lants did not locate other prior investigations of DSM-IV
IUDs in juvenile justice service populations. Thus, this
investigation examined 1) the prevalence of DSM-IV inha-
lant abuse and inhalant dependence and constituent crite-Page 2 of 11
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risk for these disorders, and 2) the latent structure of
DSM-IV IUDs and concordance between DSM-IV IUDs
and empirically-derived classes of adolescent inhalant
users identified via latent class analysis of DSM-IV IUD
diagnostic criteria. Results of this study may provide a
foundation for improved screening, treatment, and pre-
vention of IUDs in juvenile justice settings.
Methods
Survey Description
Findings of the present study are based on a survey con-
ducted in 2003 of the population of current residents of
the Missouri Division of Youth Services (MDYS), a
statewide rehabilitation system comprised of 32 residen-
tial facilities. MDYS is the legal guardian of youth commit-
ted to its care by the state's 45 juvenile courts. Of the 740
MDYS residents at the time the survey was conducted, 10
were on furlough as interviewing commenced and 2 were
transferred to another MDYS facility while interviewers
were at a facility, but before they could be interviewed. Of
the 728 adolescents available to interview, all agreed to
participate. However, 5 interviews were discontinued; 4
adolescents displayed signs or reported symptoms of psy-
chosis and one adolescent chose not to continue. The 723
adolescents who completed the interview constituted
97.7% of MDYS residents at the time interviewing was
conducted, 99.3% of residents available for interviewing,
and approximately 55.0% of adolescents committed to
MDYS care in the prior year. Thus, the present study is vir-
tually a census of the population of MDYS residents at the
time the survey was undertaken and a large, representative
sample of MDYS annual residents.
The MDYS service population is representative of delin-
quent youth in state-mandated residential care nationally
with regard to the age, gender, and number of state youth
incarcerated per 100,000 adolescents [31]. In 2000,
15.3% of MDYS residents were committed for status
offenses (e.g., running away from home, truancy), 32.4%
were committed for misdemeanors, 40.2% were commit-
ted for less serious (class C/D) felonies, and 12.1% were
committed for the most serious (Class A/B) felonies [32].
Participation in the study was voluntary. Face-to-face
interviews of adolescents were conducted using a compre-
hensive assessment inventory. All interviewers completed
an intensive one-day training session and an interview
editor was on-site at each facility as adolescents were inter-
viewed to inspect interview schedules and thereby mini-
mize interviewer omissions and errors. Interviews were
conducted in capacious rooms that provided private areas
where individual confidential interviews could be con-
ducted simultaneously with between three and six adoles-
cents. The sample recruitment protocol ensured that no
adolescent who had completed the interview at one
MDYS facility subsequently completed the interview at
another MDYS facility.
Prior to participating in the study, each youth was asked
to read an informed assent agreement, raise any questions
they had about the study, and then sign the assent form if
they felt their questions had been answered satisfactorily
and had decided to participate. The informed assent form
provided youth with detailed information about the
study, assured them they were not required to participate,
could end participation in the interview at any time, and
that their legal status would not be affected by their deci-
sion to participate or not participate in the study. The
informed assent form also provided potential participants
with the name and telephone number of a non-study and
non-university-affiliated advocate whom they could call
for more information about the study. MDYS agreed that
youth could use the telephone during business hours to
call the advocate should they desire to do so and youth
were informed of this agreement. The informed assent
form was based on a template developed by the Washing-
ton University IRB and was specifically designed for use
with pediatric populations.
As legal guardian of the youth, MDYS provided formal
permission for youth to participate in the study. This
study was approved by the MDYS Institutional Review
Board, Washington University Human Studies Commit-
tee Institutional Review Board (with prisoner representa-
tive and otherwise operating in accordance with
governing regulations for research on prisoners and
youth), federal Office of Human Research Protection (as
required for research on prisoners), and was granted a
Certificate of Confidentiality by the National Institute on
Drug Abuse (NIDA). All youth received an age-appropri-
ate explanation of their privacy rights and a copy of the
Washington University brochure, "Your Privacy Matters,"
as well as a copy of their signed informed assent agree-
ment. Participants received $10.00, which was paid to
their facility monetary accounts and a receipt for such pay-
ment along with 2 candy bars to eat during the interview.
Youth were eager to participate in the study and highly
valued the opportunity to temporarily escape their regi-
mented daily routines and discuss their attitudes and life
histories with interviewers. It is also true that word spread
rapidly through each facility about the $10.00 and candy
bars provided to recompense youth for their time and
effort.
Measures
All study participants completed the Volatile Solvent
Screening Inventory (VSSI), a structured face-to-face inter-
view. The VSSI requires approximately 45-minutes to
complete and assesses demographic characteristics, medi-Page 3 of 11
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inhalants (e.g., gasoline, paint thinner, etc.), other drug
use and substance-related problems, current psychiatric
symptoms, suicidality, trauma history, antisocial traits
and criminal activity. A detailed description of the VSSI,
its psychometrics, and a copy of the instrument itself is
available in Howard et al [27]. Consistent with DSM-IV
diagnostic guidelines, nitrite vasodilator or nitrous oxide
use was not considered inhalant use for the purposes of
this investigation [21].
Youth who reported lifetime use of one or more of the vol-
atile solvents included in the VSSI, then completed the
Comprehensive Solvent Assessment Interview (CSAI),
also described and available in Howard et al [27]. The
CSAI includes an assessment of the settings, modalities,
peer and family networks, acute medical and social conse-
quences, and other characteristics of adolescent inhalant
use. Items and diagnostic algorithms from the Diagnostic
Interview Schedule (DIS, v. IV) were included in the CSAI
to assess for the presence of DSM-IV inhalant abuse and
inhalant dependence disorders. The DIS evidences good-
to-excellent reliability for assessment of substance use dis-
orders [33]. IUD diagnoses were assigned in accordance
with DSM-IV guidelines.
Adolescent inhalant users were assigned a lifetime inha-
lant abuse diagnosis if they met one or more of four DSM-
IV criteria for inhalant abuse at some point in their life-
time (occurring within a 12-month period) and had never
met criteria for DSM-IV inhalant dependence. Inhalant
users were assigned a past-year diagnosis of inhalant
abuse if they had met one or more inhalant abuse criteria
in the year prior to entering MDYS residential care and
had never met criteria for DSM-IV inhalant dependence.
Adolescent inhalant users were assigned a lifetime inha-
lant dependence diagnosis if they met three or more of six
DSM-IV inhalant dependence criteria within a 12-month
period at some point in their lifetimes. A seventh generic
DSM-IV substance dependence criterion – withdrawal
symptoms – was not included in the inhalant dependence
criteria set per specific DSM-IV guidelines (cf., p. 258 in
DSM-IV [21]). A past-year inhalant dependence diagnosis
was assigned to inhalant users who evidenced 3 or more
inhalant dependence symptoms within the 12-month
period immediately prior to their current MDYS episode
of care.
Analytic procedures
Univariate statistics were used to describe the prevalence
of DSM-IV inhalant abuse and dependence diagnoses and
constituent criteria. Empirically-derived classes of adoles-
cent inhalant users were identified using latent class anal-
ysis based on youths' responses to DSM-IV IUD criteria.
The first LCA analysis was carried out in an exploratory
fashion to determine whether DSM-IV IUD criteria
defined discrete latent classes of adolescent inhalant users.
Specifically, rather than testing a previously specified, a
priori class solution, a series of different models was eval-
uated with regard to indices of model fit and heuristic util-
ity. A single-class model was examined first, and
additional classes were specified until no further improve-
ments in model fit were observed. The empirical fit of
latent class models was assessed with the Bayesian Infor-
mation Criterion (BIC), which measures goodness-of-fit,
and entropy statistic, a measure of relative class purity.
Finally, each latent class model was assessed by examining
overall model results and diagnostics and by comparing
youth in LCA-derived latent classes graphically in terms of
their responses to DSM-IV IUD diagnostic criteria.
A second LCA analysis was confined to adolescent inha-
lant users who met DSM-IV criteria for lifetime inhalant
abuse or inhalant dependence. The solution to this LCA
was fixed to two classes. The concordance of empirically-
derived class assignments of youth based on LCA of
responses to DSM-IV IUD diagnostic criteria and assign-
ments of youth based on standard application of DSM-IV
diagnostic criteria was then assessed.
Results
Sample description
Eighty-seven percent of youth were male and approxi-
mately forty percent reported that their family received
public assistance. Youth ranged from 11 to 20 in age
(Mean = 15.5, SD = 1.2). Most study participants lived in
small towns (39.5%, n = 286) or cities (39.1%, n = 283),
with smaller percentages residing in suburban (13.8%, n
= 100) or rural areas (7.5%, n = 54). Youth were racially
diverse, with 33.0% (n = 238) reporting an African Amer-
ican identification, 7.7% (n = 56) a bi/multi-racial identi-
fication, 3.9% (n = 28) a Latino/Latina identification, and
55.4% (n = 400) a Caucasian racial identification. These
descriptive findings and the inhalant use prevalence rate
reported below were included in Howard et al [27].
Howard et al. [27] includes additional and more specific
sample characteristics by age, grade, and proportion of
respondents with a history of head injury, perinatal injury
or illness, and physician-diagnosed mental illness.
Inhalant use
More than one-third (38.6%; n = 279) of the total sample
reported lifetime use of inhalants. The number of inha-
lants used ranged from 1 to 16 (Mean = 4.2, Median = 4.0,
SD = 3.0).
Prevalence of DSM-IV IUDs and Constituent Criteria
Inhalant abuse
Of youth with a lifetime history of inhalant use, 18.6% (n
= 52) met DSM-IV criteria for lifetime inhalant abuse andPage 4 of 11
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past-year inhalant abuse. Thus, more than four-in-five
(i.e., 80.8%) youth who met lifetime inhalant abuse crite-
ria did not meet criteria for past-year inhalant abuse.
Additional file 1 presents findings describing the preva-
lence of each DSM-IV inhalant abuse criterion in the over-
all sample, subsample of lifetime inhalant users, and
subsamples of youth meeting DSM-IV Inhalant Abuse and
Inhalant Dependence diagnoses, respectively. The most
prevalent inhalant abuse criterion was recurrent inhalant
use in situations in which it is physically hazardous,
which was reported by approximately one-third of adoles-
cent inhalant users. The least prevalent criterion was recur-
rent inhalant-related legal problems, reported by one-in-
twenty inhalant users. Although the DSM-IV nosology
excludes youth meeting inhalant dependence criteria
from eligibility for an inhalant abuse diagnosis, a substan-
tial majority (n = 63, 79.7%) of youth meeting inhalant
dependence diagnoses would also have received an inha-
lant abuse diagnosis if dual IUD diagnoses were permitted
by DSM-IV.
Our data do not allow us to examine the temporal order-
ing of inhalant abuse and dependence diagnoses. How-
ever, it is interesting to note that 115 of 279 (41.2%)
inhalant users in this sample met lifetime DSM-IV inha-
lant abuse criteria if delinquents also meeting DSM-IV
dependence criteria are included in this total. Of this
number, 42 were free of past-year inhalant abuse, had
never met dependence criteria, and thus appeared to have
matured out of inhalant abuse; 10 youth met lifetime and
past-year inhalant abuse criteria but not dependence crite-
ria and may have experienced relatively recent onset of
abuse or abuse that did not escalate to dependence; and
63 youth met criteria for both lifetime inhalant abuse and
dependence.
Inhalant dependence
Among youth who reported inhalant use, 28.3% (n = 79)
met DSM-IV criteria for lifetime inhalant dependence.
Most youth meeting lifetime inhalant dependence criteria
also met criteria for past-year inhalant dependence
(87.3%; n = 69). The most prevalent inhalant dependence
criteria were tolerance to inhalants, loss of control over
inhalant use, and continued inhalant use despite knowl-
edge of having a persistent or recurrent physical or psy-
chological problem likely to have been caused or
exacerbated by inhalant use. Even the least prevalent of
the inhalant dependence criteria were met by more than
one-in-five inhalant users.
The final column in Additional file 2 represents inhalant
users classified with a Lifetime Inhalant Use Disorder Not
Otherwise Specified (NOS). The diagnostic category was
defined as inhalant users who met 1 or 2 lifetime inhalant
dependence criteria but who did not meet diagnostic cri-
teria for either inhalant abuse or dependence. These "diag-
nostic orphans" evidenced some symptoms of inhalant
dependence but were not diagnosed with formal IUDs in
the DSM-IV diagnostic system. Diagnostic orphans were
not uncommon, comprising slightly less than one-fifth of
the sample of lifetime inhalant users. Levels of inhalant
dependence symptoms in this group were not insubstan-
tial.
Latent Structure of DSM-IV Inhalant Abuse and 
Dependence
The latent structure of DSM-IV inhalant abuse and
dependence disorders was explored by first examining
profiles of lifetime inhalant users based on DSM-IV-
defined inhalant abuse and dependence criteria. The anal-
ysis was carried out using LCA. A three-class solution
exhibited the best fit to the data (BIC = 2679, see Addi-
tional file 3) and was the most parsimonious and inter-
pretable model with class purity (entropy = .83) similar to
the 2- and 4-class models. As shown in Figure 1, each class
of inhalant users exhibited an ordinally-differentiated
profile with respect to their estimated probability of
endorsing each IUD diagnostic criterion.
Of lifetime inhalant users, the estimated percentage of
adolescents belonging to the largest group, labeled "non-
symptomatic inhalant users," was 47.0%. The percentage
of inhalant users in this class was similar to the percentage
of youth who reported lifetime inhalant use but who did
not meet DSM-IV diagnostic criteria for inhalant abuse or
dependence (i.e., 53.1%). This class exhibited the lowest
probability of endorsing any of the IUD diagnostic crite-
ria. Among nonsymptomatic inhalant users, the diagnos-
tic criteria with the highest estimated probability of
endorsement were inhalant use in physically hazardous
situations (.12) and loss of control (.12) over inhalants.
An estimated 28.3% of adolescent inhalant users were
assigned to a second group, labeled "symptomatic inha-
lant users." The percentage of inhalant users in this class
was somewhat higher than the percentage of users classi-
fied with DSM-IV-defined inhalant abuse (i.e., 18.6%).
Members of this class were more likely to endorse most
inhalant abuse criteria compared to nonsymptomatic
inhalant users, but were significantly less likely to endorse
inhalant abuse criteria than members of the third LCA-
derived group of inhalant users. Compared to nonsymp-
tomatic inhalant users, symptomatic users also had sub-
stantially higher estimated probabilities of endorsing all
six inhalant dependence criteria.
The estimated percentage of adolescents belonging to the
third LCA-derived class of inhalant users, labeled "highlyPage 5 of 11
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lant users in this class was similar to the proportion of
users classified with DSM-IV-defined inhalant depend-
ence (i.e., 28.3%). This group exhibited significantly
higher estimated probabilities of endorsing each DSM-IV
IUD criterion than did the other two inhalant user classes.
For the abuse criteria, the highest estimated probability of
endorsement was for recurrent inhalant use resulting in a
failure to fulfill major role obligations at work, school, or
home (.86), followed by recurrent inhalant use in physi-
cally hazardous situations (.82). The probability of expe-
riencing any of the DSM-IV inhalant dependence criteria
was significantly elevated in this class compared to the
classes of nonsymptomatic and symptomatic inhalant
users. Members of this class evidenced a .55 to .88 proba-
bility of endorsing each DSM-IV inhalant dependence cri-
terion.
Overall, 8 of 10 DSM-IV IUD criteria clearly differentiated
nonsymptomatic inhalant users from symptomatic inha-
lant users and 6 of these were inhalant dependence crite-
ria. All DSM-IV IUD criteria usefully differentiated
symptomatic inhalant users from highly symptomatic
inhalant users, especially recurrent inhalant use resulting
in a failure to fulfill major role obligations, inhalant use
in physically hazardous situations, continued inhalant
use despite persistent/recurrent inhalant-related social/
interpersonal problems, great deal of time spent in activi-
ties necessary to obtain, use, or recover from the effects of
inhalants, and important social, occupational, or recrea-
tional activities given up because of inhalant use.
The correspondence of DSM-IV IUD diagnoses and LCA-
based diagnoses of nonsymptomatic, symptomatic, and
highly symptomatic inhalant users was examined in Addi-
tional file 4. In general, there was a moderately high cor-
respondence between both nosologies for the most and
Exploratory Latent Class Analysis of Lifetime Adolescent Inhalant Users' (N = 279) Responses to DSM-IV Inhalant Use Disor-der (i.e., Abuse a d Dependence) Diagnostic CriteriaFigur  1
Exploratory Latent Class Analysis of Lifetime Adolescent Inhalant Users' (N = 279) Responses to DSM-IV Inha-
lant Use Disorder (i.e., Abuse and Dependence) Diagnostic Criteria.
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DSM-IV inhalant Dependence-LCA highly symptomatic
use and DSM-IV no inhalant diagnosis-LCA nonsympto-
matic). It is also notable that DSM-IV tended to classify
more inhalant users into both the inhalant dependence
(28.3%) and no inhalant abuse or dependence disorder
(53.0%) groups, than the LCA-derived nosology assigned
to their highly symptomatic (24.7%) and nonsympto-
matic (47.0%) group counterparts. Significantly less cor-
respondence was observed for the DSM-IV inhalant
abuse-LCA symptomatic group. The LCA-based nosology
was significantly more likely to assign an inhalant user to
the symptomatic group than the DSM-IV nosology was to
assign an inhalant abuse diagnosis (28.3% vs. 18.6%).
Of the 52 inhalant users meeting DSM-IV NOS criteria
(i.e., who did not meet full diagnostic criteria for either
inhalant abuse or dependence, but who met 1 or 2 inha-
lant dependence criteria), 14 (26.9%) were assigned to
the LCA symptomatic group and 38 (73.1%) to the LCA-
nonsymptomatic group. Thus, discrepancies between the
DSM-IV and LCA-derived nosologies are attributable, in
part, to the greater sensitivity of the LCA-based nosology
to detect of youth with significant inhalant-related prob-
lems that were subthreshold for receipt of DSM-IV inha-
lant abuse or dependence diagnoses.
The validity of DSM-IV inhalant abuse and dependence
disorders was assessed using LCA. This procedure
involved subjecting all inhalant users' responses (yes/no)
to DSM-IV inhalant abuse and dependence criteria to LCA
including only youth who were diagnosed with DSM-IV
inhalant abuse or dependence. The model was restricted,
a priori, to a two-class solution to determine whether a
clear distinction between disorders of abuse and depend-
ence could be discerned. The overall model exhibited a
good fit to the data (BIC = 1575, Entropy = .77).
The estimated probabilities of youth in these two classes
endorsing each diagnostic criterion are presented in Fig-
ure 2. The two groups derived via LCA exhibited distinct
ordinally-differentiated sets of estimated probabilities of
endorsing DSM-IV IUD criteria. Approximately 52.7% of
inhalant users were assigned to the class with higher esti-
mated probabilities of criterion endorsement across all
IUD diagnostic criteria, which was again labeled "highly
symptomatic inhalant users." Approximately 47.3% of
inhalant users with IUDs were assigned to the class with
lower estimated probabilities of IUD diagnostic criterion
endorsement and were labeled "symptomatic users."
Inhalant users were assigned to their respective classes
based on the LCA model and then the LCA and DSM-IV-
based classifications were compared across inhalant users.
Seventy-seven subjects were assigned to the highly symp-
tomatic class using LCA; 59 (74.7%) of these youth met
DSM-IV criteria for inhalant dependence disorder, the
remainder met DSM-IV inhalant abuse criteria. Sixty-four
subjects were assigned to symptomatic inhalant user
group via LCA, 42 (80.8%) of these youth met DSM-IV cri-
teria for inhalant abuse; the remaining 19.2% were diag-
nosed with DSM-IV-defined inhalant dependence.
Discussion
Summary of Findings
Inhalant use disorders were found at a considerably
higher level in this large sample of juvenile justice system-
involved youth than generally found in community sam-
ples of adolescents. Of the 279 (38.5%) youth who
reported lifetime inhalant use, 131 (47.0%) met criteria
for a DSM-IV IUD. Thus, the overall burden of DSM-IV
IUDs in this population is estimated at 18.1%, with nearly
one-in-five youth affected by these disorders.
That nearly one-half of all adolescent inhalant users devel-
oped formal DSM-IV IUDs further suggests that the abuse
liability of inhalants among youth in the juvenile justice
system is much higher than would be expected on the
basis of prior studies of community and clinical popula-
tions of inhalant users [29,30]. Historically, inhalants
have been thought to have low abuse liability, although
this assumption has to some extent been based on find-
ings from large national surveys of inhalant use that
excluded institutional populations of delinquent and psy-
chiatrically-disordered youth. Although the findings of
this investigation suggest that IUDs are prevalent in this
juvenile justice client population, it is also possible that
Missouri youth more generally are at high risk for IUDs.
Ridenour, Bray, and Cottler [34] recently reported that
40.3% of the 162 adolescent/young adult (M = 20.3, SD =
2.4) community-based inhalant users they studied in St.
Louis, Missouri met criteria for an IUD.
In this study of adolescent inhalant users, inhalant
dependence was more prevalent than abuse (Depend-
ence: 28.3% vs. Abuse: 18.6%), whereas Ridenour et al
[34]. found that 12.4% of the adolescent/young adult
inhalant users they studied met inhalant dependence cri-
teria and 27.9% met inhalant abuse criteria. Further, in
this study four-of-five youth with lifetime inhalant abuse
did not meet criteria for past-year inhalant abuse. Thus,
inhalant abusers appeared to have largely discontinued
problematic inhalant use. Conversely, most youth who
were diagnosed with lifetime inhalant dependence also
met past-year criteria for inhalant dependence, suggesting
that inhalant dependence was persistent in its course fol-
lowing onset or had developed within the year prior to
assessment. In the absence of data pertaining to age at
onset of inhalant dependence, it was not possible to deter-
mine the proportions of inhalant dependent youth who
were persistently inhalant dependent over several yearsPage 7 of 11
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inhalant dependence who may or may not become per-
sistently inhalant dependent. Nonetheless, these findings
suggest that inhalant dependent youth may be a discrete
group that could benefit from targeted interventions of an
intensive nature.
Given the young average age of the sample, the finding
that nearly 90% of youth with lifetime inhalant depend-
ence met past-year criteria for inhalant dependence, and
that many dependent youth also met DSM-IV inhalant
abuse criteria, it is possible that a significant number of
adolescent inhalant users transitioned from inhalant
abuse to dependence in their middle-teenage years. Future
studies should examine the timing and patterns of transi-
tions between inhalant use, abuse, and dependence.
With the exception of legal problems, specific signs and
symptoms of IUDs were prevalent in this adolescent pop-
ulation. For example, 23.7%, 32.6%, 5.0%, and 21.1% of
inhalant users met role failure, hazardous use, legal prob-
lems, and social problems inhalant abuse criteria. Com-
parable figures for Ridenour et al.'s [34] sample of
community-based adolescent/young adult inhalant users
were: 8.9%, 24.8%, 0.0%, and 8.9%. Thus, the general
pattern of findings for inhalant abuse criteria was similar
for inhalant users in the current study and Ridenour et
al.'s study of community-based inhalant users, but preva-
lence rates were notably higher among youth in this juve-
nile justice sample.
In this study and Ridenour et al.'s [34] investigation, con-
tinued inhalant use despite inhalant-related physical and
psychological problems and inhalants taken in larger
amounts or longer than intended, were among the most
prevalent inhalant dependence criteria among inhalant
users (albeit rates were higher in this sample). However,
other dependence symptoms were much more prevalent
Latent Class Analysis (Constrained to 2-Group Solution) of Adolescent Inhalant Users' (N = 131) Responses to DSM-IV Inha-lant Use Di order Diagn stic Criteria (note: all inhalant users in this analysis met criteria for either DSM-IV inhalant abuse or depend nce)Figure 2
Latent Class Analysis (Constrained to 2-Group Solution) of Adolescent Inhalant Users' (N = 131) Responses to 
DSM-IV Inhalant Use Disorder Diagnostic Criteria (note: all inhalant users in this analysis met criteria for 
either DSM-IV inhalant abuse or dependence).
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the study conducted by Ridenour et al [34]. These findings
suggest that problematic inhalant use and formal IUDs
are comparatively prevalent among delinquent youth.
Comparison of LCA and DSM-IV Classifications
Diagnostic concordance
Latent class analyses of DSM-IV inhalant abuse and
dependence criteria yielded clearly identifiable, ordinally-
differentiated patterns of criterion endorsement for non-
symptomatic, symptomatic and highly symptomatic
inhalant users [34,35]. Further, a moderately-high level of
correspondence between the LCA-derived and DSM-IV-
assigned classifications was observed, particularly for the
LCA highly symptomatic-DSM-IV dependence and LCA
nonsymptomatic-DSM-IV no diagnosis groups. DSM-IV
inhalant abuse diagnoses were much less concordant with
LCA-based diagnoses than other DSM-IV inhalant-related
diagnoses.
DSM-IV inhalant abuse and dependence diagnoses
appeared to distinguish two groups of persons with inha-
lant-related problems differing primarily in severity,
although the specific abuse and dependence criteria may
function differently than conceptualized in DSM-IV. Spe-
cifically, DSM-IV inhalant abuse and dependence diag-
noses did not appear to divide problem inhalant users
into discrete groups with high abuse-low dependence and
low abuse-high dependence symptom profiles. Rather,
across all DSM-IV IUD criteria – abuse and dependence –
LCA-defined highly symptomatic users had higher rates of
symptom endorsement than did LCA-symptomatic users.
To what extent these findings are attributable to the hier-
archical nature of the DSM-IV inhalant abuse and depend-
ence diagnoses, which do not allow persons to receive an
inhalant abuse diagnosis if they have received an inhalant
dependence diagnosis, but do allow persons diagnosed
with inhalant dependence to also meet an inhalant abuse
diagnosis is not clear. The fact that three criteria must be
met to receive an inhalant dependence diagnosis (com-
pared to one for inhalant abuse) and the hierarchical
nature of the inhalant dependence diagnosis, undoubt-
edly contribute to the notable differences between inha-
lant users meeting abuse and dependence criteria with
regard to problem severity.
Criterion-level analyses
At the diagnostic level, results summarized above suggest
potential problems with the conceptualization and/or
assessment of DSM-IV inhalant abuse. Criterion-level
findings provided further indication that some inhalant
abuse criteria may lack discriminant validity. Study find-
ings suggested that DSM-IV inhalant dependence criteria
performed well in distinguishing nonsymptomatic, symp-
tomatic, and highly symptomatic inhalant users in both
LCA analyses. However, when examining all inhalant
users, inhalant abuse criteria did not perform well in dif-
ferentiating nonsymptomatic and symptomatic inhalant
users. Additionally, when examining only subjects who
met DSM-IV criteria for abuse or dependence, two of four
inhalant abuse criteria (i.e., recurrent use in hazardous sit-
uations and inhalant-related legal problems) did not
clearly distinguish symptomatic and highly symptomatic
inhalant users. These findings are consistent with those of
other studies that suggest abuse symptoms, such as recur-
rent use in hazardous situations and substance-related
legal problems, do not effectively discriminate problem
severity [25].
Reasons for Discrepancies
It is important to consider factors that might account for
discrepancies between diagnostic approaches. One expla-
nation relates to the significant heterogeneity among
inhalant users in general and within the DSM-IV con-
structed groups specifically. Like other studies of inhalant
use, this study did not account for types or modes of inha-
lant use, which can lead to fundamentally different bio-
logical, social, and psychological consequences. Prior
descriptive studies with this sample of delinquent youth
revealed a wide range of inhalants used and modes of use,
in addition to high rates of polyinhalant use [27]. Thus, it
is reasonable to expect varied clinical profiles in the sam-
ple. Because the DSM-IV classifies individuals using a pol-
ythetic formulation (i.e., a proportion of the overall set of
diagnostic criteria must be met to receive a given diagno-
sis), whereas the LCA seeks individuals with similar pat-
terns in response sets, some discrepancies are expected.
Another potential explanation for discrepancies between
the two diagnostic approaches relates to the conceptuali-
zation of problematic inhalant use. The DSM-IV classifies
abuse and dependence as separate disorders. This classifi-
cation was supported, in part, with the LCA. However, the
underlying assumption of the DSM-IV classification is
that the proper way to model problematic inhalant use is
assuming a categorical variable when, in fact, the problem
may be continuously distributed. Thus, both DSM-IV and
LCA are prone to error if they are classifying people with a
disorder that exists on a theoretical continuum. This is not
to argue against the utility of a categorical formulation,
but to highlight the sources that may account for discrep-
ancies between the two approaches. Future research
should examine problematic inhalant use as a continuous
variable using both factor analytic methods and item
response theory to better understand the nature of IUDs
and how they should be measured.
Discrepancies between diagnostic approaches might also
be due to the relatively large group of diagnostic orphans,
who evidenced one or two signs/symptoms of inhalantPage 9 of 11
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when DSM-IV criteria were applied. The existence of a siz-
able group of diagnostic orphans with clinically signifi-
cant inhalant dependence signs and symptoms that go
undiagnosed under current DSM-IV diagnostic protocols
could be one argument in favor of a unidimensional
approach to the conceptualization and assessment of
inhalant use disorders (i.e., dependence).
Limitations and Future Directions
Limitations of this report include the self-report nature of
the data (biochemical assays are currently largely unavail-
able or infeasible for inhalant use assessment), and uncer-
tain reliability of the DIS assessment of DSM-IV IUD
diagnostic criteria. Few studies of the reliability of DSM-IV
IUD assessments have been reported [34,36]. The DIS is
one of the oldest and most well established measures of
DSM-IV substance use disorders, but caution is urged in
the interpretation of these findings until additional relia-
bility studies of DIS-assessed DSM-IV IUDs are per-
formed. Another key limitation of the reported research is
that the authors' cannot place IUDs in the context of other
DSM-IV substance use disorders or non-substance-related
psychiatric disorders because these conditions were not
assessed via structured psychiatric interview in this inha-
lant-focused study. Information about comorbid sub-
stance use and psychiatric disorders could help guide
treatment responses and enhance the efficacy of inhalant
treatment interventions. Finally, although the antisocial
nature of the sample we examined might limit the gener-
alizability of reported findings, we note that antisocial
youth are an important and understudied population in
their own right, antisocial behavior is a common concom-
itant of substance use disorders in the general population,
and that our sample included the full gamut of antisocial
youth, ranging from those with minor behavioral prob-
lems to the severely antisocial.
Conclusion
IUDs and several individual IUD criteria were prevalent in
this sample of antisocial youth. A number of youth met
one or two inhalant dependence criteria but did not meet
DSM-IV criteria for inhalant abuse or dependence. These
diagnostic orphans evidenced worrisome inhalant-related
problems that are not captured by the current set of IUD
diagnostic criteria in DSM-IV. Study findings provided
evidence for distinct classes of symptomatic and highly
symptomatic inhalant users identified via latent class
analyses of DSM-IV inhalant abuse and dependence crite-
ria. Relatively high levels of correspondence were identi-
fied for LCA-derived and DSM-IV-defined diagnoses of
LCA-highly symptomatic inhalant use/DSM-IV inhalant
dependence and LCA nonsymptomatic/DSM-IV no diag-
nosis groups. Data were less supportive at the diagnostic
and criterion levels of the validity of the DSM-IV abuse
diagnosis. The ability to identify groups of inhalant users
differing in the severity of their IUDs may be important
for treatment purposes. The results of this investigation
establish the need for IUD screening, prevention, and
treatment interventions directed to the more than one
million youth who are annually involved with the juve-
nile justice system. Future research should also focus on
the question of how wide the nomological net should be
cast in an effort to capture all youth displaying inhalant-
related problems in contemporary diagnostic schemes.
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